SkyePharma PLC is a pharmaceutical company. The Company validates drug delivery technologies to develop oral and inhalation pharmaceutical products. The Company operates in United Kingdom, Rest of Europe, North America and Rest of world. The principal activities of the Company included the research and development, manufacture and sale of prescription pharmaceutical products. The Company is engaged in the development and manufacture of pharmaceutical products based on information used internally by management to assess the performance of, and allocate resources to the business. The Company�s subsidiaries include SkyePharma Production SAS, SkyePharma (Jersey) Limited, Jago Holding AG, Jagotec AG, SkyePharma AG, SkyePharma Holding AG and SkyePharma Holding Inc.